UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway

Wang Y, Gao G, Wei X, Zhang Y, Yu J

Drug Design, Development and Therapy 2023, 17:1357-1369

Published Date: 5 May 2023